(
out of
35
reviews
)
Clinical Locations
Primary Location
Huntsman Cancer Institute - Cancer Hospital South
Clinic 2B, Genetics/Family Cancer Assessment
1950 Circle of Hope
Salt Lake City
,
UT
84112
Specialties
Board Certification
|
American Board of Genetic Counseling
|
Patient Rating
Patients consistently describe Jennie as warm, compassionate, and personable, saying she makes them feel comfortable and reassured. Reviewers repeatedly praise her clear, thorough explanations of genetics and testing, her patience in answering questions, and her strong clinical knowledge. Many also note personalized follow-up planning, attentive communication, and a teaching approach that helps patients and families understand their care.
Generated via Patient Reviews
5.0
/5
( out of
35 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Huntsman Cancer Institute
-Midlevel Internal Medicine -Adjunct Assistant Professor |
|---|---|
| Academic Divisions |
Oncology
|
| Board Certification |
American Board of Genetic Counseling
|
Selected Publications
Journal Article
- Moses R, Indeglia A, Levine AS, Hausler R, Kelly G, Miller SA, Anez I, Heller M, Delgado R, Orr C, Kohlmann W, Naumer A, Vagher J, Cahill SR, Maese LD, Karanicolas J, Garber JE, Murphy ME, Maxwell K (2026). Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosis. Molecular cancer research,
- Spiegel SR, Orr C, Edgar NU, Cahill SR, Le AN, Good M, Lyman J, Feola S, Mehrhoff C, Naumer A, Vagher J, Anez I, Frucht N, Maese LD, Garber JE, Maoz A, Katona BW, MacFarland SP, Maxwell K (2026). Colorectal Neoplasia Rates in Li-Fraumeni Syndrome. The American journal of gastroenterology,
- Wen T, Boyden SE, Hocutt CM, Lewis RG, Baldwin EE, Vagher J, Andrews A, Nicholas TJ, Chapin A, Fan EM, Botto LD, Bayrak-Toydemir P, Mao R, Meznarich (2025). Identification of two novel non-coding variants in Diamond-Blackfan Anemia Syndrome patients by whole genome sequencing. Blood advances, 9(10), 2443-2452.
- Stubbins RJ, Arnovitz S, Vagher J, Asom A, Perpich M, Pies M, Akpan IJ, Chew E, Bridgers J, Karsan A, Rodgers C, Koppayi A, Basdag H, Drazer MW, Das S, Cheng J, Osman AEG, Godley L (2025). Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants. Leukemia,
- Vagher J, Zakas A, Donovan L, Shoger K, Naumer A, Bly J, Smith-Simmer K, Maese L, Schiffman J, Kohlmann W, Garzon R, Churpek JE, Osman AE (2025). Hematologic Malignancy Frequency, Phenotypes, and Outcomes in Li-Fraumeni Syndrome. JCO precision oncology, 9, e2400860.
- Moses R, Indeglia A, Levine AS, Hausler R, Kelly G, Miller SA, Anez I, Heller M, Delgado R, Orr C, Kohlmann W, Naumer A, Vagher J, Cahill SR, Maese LD, Karanicolas J, Garber JE, Murphy ME, Maxwell K (2025). Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosis. bioRxiv,
- Sleiman MM Jr, Statman MR, Yockel MR, Wu YP, Hamilton JG, Kohlmann WK, Vagher J, Feola S, Maese LD, Chen J, Appel B, Mehrhoff CJ, Peshkin BN, Kadan-Lottick NS, Kupfer GM, Tercyak K (2025). Parental perspectives on the use of tumor molecular profiling and germline genetic testing during their children's cancer treatment. Familial cancer, 24(3), 63.
- Beigh M, Vagher J, Codden R, Maese LD, Cook S, Gammon (2024). Newborn Screening for Li-Fraumeni Syndrome: Patient Perspectives.
- Fan EM,Vagher J,Meznarich JA,Ubico EM,Goteti S,Peterson D,Rayes A,Maese L (2023). Severe congenital neutropenia, SRP54 pathogenicity, and a framework for surveillance. American journal of medical genetics. Part A, 191(5), 1434-1441.
- Li P, Brown S, Williams M, White TA, Xie W, Cui W, Peker D, Lei L, Kunder CA, Wang HY, Murray SS, Vagher J, Kovacsovics T, Patel J (2022). The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms. Blood, 140, 716-755.
- Harriman JW, Espinel WF, Vagher J, Gammon (2022). BRCA1/2 Variants Identified Through Tumor Genomic Profiling: Assessing Genetic Counseling Outcomes. JCO precision oncology, 6, e2100375.
- Maxwell KN, Cheng HH, Powers J, Gulati R, Ledet EM, Morrison C, Le A, Hausler R, Stopfer J, Hyman S, Kohlmann W, Naumer A, Vagher J, Greenberg SE, Naylor L, Laurino M, Konnick EQ, Shirts BH, AlDubayan SH, Van Allen EM, Nguyen B, Vijai J, Abida W, Carlo MI, Dubard-Gault M, Lee DJ, Maese LD, Mandelker D, Montgomery B, Morris MJ, Nicolosi P, Nussbaum RL, Schwartz LE, Stadler Z, Garber JE, Offit K, Schiffman JD, Nelson PS, Sartor O, Walsh MF, Pritchard C (2021). Inherited TP53 Variants and Risk of Prostate Cancer. European urology, 81, 243-250.
- Li P, White T, Xie W, Cui W, Peker D, Zeng G, Wang HY, Vagher J, Brown S, Williams M, Kovacsovics T, Patel J (2021). AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome. Leukemia, 36, 664-674.
- Iglesias Cardenas F, Agarwal AM, Vagher J, Maese L, Fluchel M, Afify (2021). Two Clonally Distinct B-Cell Lymphomas Reveal the Diagnosis of XLP1 in a Male Child and His Asymptomatic Male Relatives: Case Report and Review of the Literature. Journal of pediatric hematology/oncology, 43(8), e1210-e1213.
- Chavez-Yenter D, Vagher J, Clayton MF, Rindler M, Shukovich M, Kaphingst K (2021). "Being proactive, not reactive": exploring perceptions of genetic testing among White, Latinx, and Pacific Islander Populations. Journal of community genetics, 12(4), 617-630.
- Thomsen W, Maese L, Vagher J, Moore K, Cheshier SH, Hofmann JW, Bruggers (2021). Early Presentation of Homozygous Mismatch Repair Deficient Glioblastoma in Teen With Lynch Syndrome: Implications for Treatment and Surveillance. JCO precision oncology, 5, 670-675.
- Maxwell KN,Cheng HH,Powers J,Gulati R,Ledet EM,Morrison C,Le A,Hausler R,Stopfer J,Hyman S,Kohlmann W,Naumer A,Vagher J,Greenberg SE,Naylor L,Laurino M,Konnick EQ,Shirts BH,AlDubayan SH,Van Allen EM,Nguyen B,Vijai J,Abida W,Carlo MI,Dubard-Gault M,Lee DJ,Maese LD,Mandelker D,Montgomery B,Morris MJ,Nicolosi P,Nussbaum RL,Schwartz LE,Stadler Z,Garber JE,Offit K,Schiffman JD,Nelson PS,Sartor O,Walsh MF,Pritchard C (2021). Inherited TP53 Variants and Risk of Prostate Cancer. European urology, 81(3), 243-250.
- Himes DO,Vagher (2020). Patient With Questions About Cancer Risk. European urology, 16(7), e109-e112.
- Landrith T,Li B,Cass AA,Conner BR,LaDuca H,McKenna DB,Maxwell KN,Domchek S,Morman NA,Heinlen C,Wham D,Koptiuch C,Vagher J,Rivera R,Bunnell A,Patel G,Geurts JL,Depas MM,Gaonkar S,Pirzadeh-Miller S,Krukenberg R,Seidel M,Pilarski R,Farmer M,Pyrtel K,Milliron K,Lee J,Hoodfar E,Nathan D,Ganzak AC,Wu S,Vuong H,Xu D,Arulmoli A,Parra M,Hoang L,Molparia B,Fennessy M,Fox S,Charpentier S,Burdette J,Pesaran T,Profato J,Smith B,Haynes G,Dalton E,Crandall JRR,Baxter R,Lu HM,Tippin-Davis B,Elliott A,Chao E,Karam (2020). Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes. NPJ precision oncology, 4(1),
- Moody EW, Vagher J, Espinel W, Goldgar D, Hagerty KJ, Gammon (2019). Comparison of Somatic and Germline Variant Interpretation in Hereditary Cancer Genes. JCO precision oncology, 3, 1-8.
Review
- Greenberg SE, Skefos CM, Vagher (2026). Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations. Endocrinology and metabolism clinics of North America, 55(2), 299-315.
- Courtwright A, King RA, Vagher J, Levy CT, Orozco JGF, Batista LF, Osman A, Tantavahi S, Scholand M (2026). A Proposed Clinical Diagnostic Framework for Short Telomere Syndrome. Clinical genetics,
- Vagher J, Mehrhoff CJ, Florou V, Maese L (2024). Genetic Predisposition to Sarcoma: What Should Clinicians Know?. Current treatment options in oncology, 25(6), 769-783.
- Vagher J, Gammon A, Kohlmann W, Jeter (2022). Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders. Frontiers in oncology, 12, 837059.
- Vagher J,Dietz MS,Schiffman JD,Kohlmann W,Maese (2022). Germline predisposition to soft tissue sarcoma. Journal of cancer metastasis and treatment, 8,
Book Chapter
- Vagher J,Maese L,Gammon A,Kohlmann W,Schiffman J (2021). Inherited risk for childhood leukemia. The Hereditary Basis of Childhood Cancer, 315-360.
Case Report
- Franke K, Vagher J, Boyle J, Hall A, Smith-Simmer (2022). Rare variant in the fumarate hydratase gene found in patients with clinical features of hereditary leiomyomatosis and renal cell cancer (HLRCC): A case series. Clinical case reports, 10(3), e05513.
- Kerrigan K, Chan J, Vagher J, Kohlmann W, Naumer A, Anson J, Low S, Schiffman J, Maese (2021). Lung Cancer in Li-Fraumeni Syndrome. JCO precision oncology, 5,
- Rathi N, Anderson N, Greenberg S, Vagher J, Agarwal N, Hahn A (2018). DNA Damage Repair (DDR) Mutations and the Utility of High-Risk Genetics Clinics in Metastatic Castration-Refractory Prostate Cancer (mCRPC). World journal of oncology, 9(4), 119-122.
Letter
- Tantravahi SK, Huber BD, Vagher J, Maese L, Pomicter AD, Al-Sweel N, Asch JD, Toydemir RM, Hong B, Parker (2022). Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemia. British journal of haematology, 198(6), e78-e81.
Thank you.
She's amazing really took her time
You're the best. Thank you for such a fun, thoughtful and professional visit. You were extremely helpful and knew your stuff. Helped me be at ease.
Very kind
Fantastic help and encouragement
Professional and caring. She earned my trust and I would go back to her in a heartbeat.
Very professional...knew her subject matter ...explained concepts clearly
Very attentive and empathetic. [TRANSLATED]
Real pleasure to discuss our situation with Jennie. She was very well versed, knowledgeable and helpful. Excited to continue to work with her.
Thanks for your help understanding our illness
She's great and does her job well.
Jennie was so kind and easy to talk with about the test results. I learned a lot from her.
Jennie is amazing! She is kind and attentive. Most of all she does her best to see that all matters for you are taken care of.
Very professional & pleasant to talk to
She was so sweet and bonded with our daughter immediately. She asked us a lot of history and answered all our questions. She made us feel safe and reassured in this scary time.
Jennie was wonderful - empathetic, thoughtful, and knowledgeable.
Jennie took a personal interest in our family genetics and is aggressive in connecting as many dots together as possible. She is detailed and thorough.
She's a friendly and caring person who also is a very good explainer.
Jennie has an exceptional gift of being able to teach the patient about their care and the benefits that will come in the future for the patient and generations to come.
Jennie Vagher was amazing. She did such a great job at interacting with Adrian and my daughter and was very good at explaining everything on their level.
Ms. Vagher was relaxed and open and very helpful explaining to us what we wanted to kno.
I had a very positive experience! They were very warm and friendly and very informative!
Compassionate care and thorough researching and knowledge of our daughter's extremely rare genetic condition. Excellent communication and thorough follow up of future plans. Looking forward to continuing to work with Jenny.
Very helpful.
Jennie explained the process well, and listened carefully and answered all questions great.
She is wonderful!
Very nice and knowledgeable
Jennie is amazing! She provided a thorough explanation of my genetic situation and what to expect for the testing process. And was prepared for the appointment and very knowledgeable about my condition. Her expertise was very appreciated!
Very professional and polite and explained everything throughly
Exceptionally caring and knowledgeable provider!!
She was great to talk to and helped me understand.
She was amazing! She made us feel so comfortable and answered any question we asked. Her expertise in the field of genetics was very obvious and helpful.
Jenn my was personable and warm, and answered all of my questions with patience and kindness. She told me my future screening options and we made a plan for next steps. I trust her to help me figure out a follow up plan post-surgery that will work for me.
Jennie was very patient, respectful, and allowed as much time as I needed for questions. 10/10 wonderful person.
What a wonderful person! So caring, thorough & compassionate
Jennie was so knowledgeable and helpful! She made me feel at ease throughout the whole procedure.